Presseinformationen weltweit an Journalisten und Leser verbreiten
. Quote from Pierre-Alain Ruffieux, Chief Executive Officer, Lonza: “We congratulate Moderna on this important milestone, which represents a significant scientific achievement and serves as a testament to Moderna’s commitment to controlling the COVID-19 pandemic. “We are proud Mehr
Pierre-Alain Ruffieux today commences his role as Chief Executive Officer, following his appointment in June 2020. Albert M. Baehny resumes his role as Chairman of the Board of Directors, after a year in the role of Chief Executive Officer ad Mehr
Lonza provides the details of its new structural design, culture and external reporting 2023 Group guidance: double-digit sales growth, CORE EBITDA margin of around 33% – 35% and double-digit ROIC CAPEX in 2021 and 2022 is likely to remain at Mehr
Strong operational performance maintained during COVID-19; sites remained open and protection of employees continues to be a top priority Landmark ten-year collaboration with Moderna on the mRNA1 platform. The current focus is to manufacture an mRNA-based vaccine (mRNA-1273) for the novel Mehr
• Sven Abend has decided to resign from Lonza to take a CEO position in Germany. • Recruitment plans are under way to appoint a permanent replacement. • LSI is performing well and the segment carve-out process is nearing completion. Mehr
The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective 1 November 2020. Pierre-Alain is currently Head of Global Pharma Technical Operations at Roche where he and his 12,000-strong team are responsible for Mehr
Dr Moncef Slaoui has decided to step down from his position as a member of the Lonza Group Board of Directors, following his appointment to the role of Chief Advisor for the U.S. government’s “Warp Speed” national vaccine program. Lonza Mehr
Collaboration goal to enable manufacturing of up to 1 billion doses per year Technology transfer expected to begin in June 2020 First batches of mRNA-1273 expected to be manufactured at Lonza U.S. in July 2020 Collaboration leverages Lonza’s worldwide expertise Mehr
44,965,404 shareholders delegated their votes to the independent proxy, representing 60.38% of the share capital Shareholders re-elected all existing members of the Board of Directors who stood for re-election and elected Dorothée Deuring and Moncef Slaoui as new members of Mehr
Due to COVID-19, Lonza provides the following update outside of the regular reporting cycle: Group net sales reached CHF1.6 billion in Q1, up 7.4% quarter-on-quarter in constant exchange rate (CER). LPBN net sales increased by 8.3% quarter-on-quarter CER, reaching Mehr